Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Topotecan Kemex


Contraindicated

Contraindicated
Topotecan Kemex :
Type Medicine Rejected
Originator Hycamtin Injectable
Agent C. Catafago & Co
Distributor C. Catafago & Co
Laboratory Kemex
Manufacturer Laboratorio Kemex SA
Manufacturing Type G
Origin Argentina
ATC L01XX17

Your comment will appear shortly after approval

Topotecan Kemex :

Revision Date : 24/04/2015


Effect Frequency
Abdominal pain Very Common
Alopecia Very Common
Anaemia Very Common
Anaphylactic reactions Rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Rare
Asthenia Very Common
Constipation Very Common
Decreased appetite Very Common
Diarrhoea (Diarrhea) Very Common
Extravasation Very rare
Fatigue Very Common
Febrile neutropenia (Neutropenic fever) Very Common
Haemorrhage Not known
Hyperbilirubinaemia Common
Hypersensitivity Common
Infection Very Common
Interstitial pneumonitis Rare
Leucopenia (Leukopenia) Very Common
Malaise Common
Mucosal inflammation Very Common
Nausea Very Common
Neutropenia Very Common
Neutropenic colitis Not known
Pancytopenia Common
Pruritus Common
Pyrexia Very Common
Sepsis (Systemic infection) (Sepsis state) Common
Skin rash Common
Thrombocytopenia (Thrombopenia) Very Common
Tumour haemorrhage Not known
Urticaria Rare
Vomiting Very Common

Different Units By MoH Code

Topotecan Kemex  MoH 2060082 :
Form Powder for solution for injection
Packaging Bottle
Package Size Box of 1
Strength 4mg
Stratum N/A
NSSF ✘
Quarantine ✘
Submission date 01/01/2015
Rejection Year 2015
Rejection Reason Incomplete study


Price Comparison

● Country: Argentina
● Package Size: 1
● Medica Comments: Not available in the country of origin
● Reference: Ministerio de Salud
● Pricing Date: 14/10/2019
● Type: Medicine not available

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info